Ahmed S, Autrey J, Katz I.T, Fox M.P, Rosen S, Onoya D, Bärnighauseng T, Kenneth H. Mayer K.H, Bor J. Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Social Science

Berhanu RH, David A, da Silva P, Shearer K, Sanne I, Stevens W, Scott L. Performance of Xpert MTB/RIF, Xpert Ultra,and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting. J ClinMicrobiol. 2018 Nov 27;56(12). pii: e00560-18. doi: 10.1128/JCM.00560-18. Print 2018 Dec.

Bonawitz R, Brennan AT, Long L,Heeren T, Maskew M, Sanne I, and Fox M.P. Regimen durability in HIV-infected children and adolescents initiating first-line antiretroviral therapy in a large public sector HIV cohort in South Africa.Tropical Medicine and International Health, June 2018, 23:6(650-660), doi:10.1111/tmi.13057,

Bor J, Chiu C, Ahmed S, Katz I, Fox M. P, Rosen S,Yapa M, Tanser F, Pillay D, Bärnighausen T.Failure to initiate HIV treatment in patients with high CD4 counts: evidence from demographic surveillance in rural South Africa. Trop Med Int Health (2018). 23(2): 206–220. INROADS

Botha J, Conradie F, Etheredge H Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options. AIDS 2018, 32:16, doi:10.1097/QAD.0000000000002000.

Brennan A.T, Bor J, Davies M, Wandeler W, Prozesky H, Fatti G, Wood R, Stinson K, Tanser F, Bärnighausen T, Boulle A, Sikazwe I, Zanolini A, and Fox M.P Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia. AJE Vol. 187, No. 9 DOI: 10.1093/aje/kwy093 INROADS

Brennan A.T, Jamieson L, Crowther N.J, Fox M.P, George J.A, Berry K.M, Stokes A, Maskew M, Sanne I, Long L, Cassim N, Rosen S.Prevalence, incidence, predictors, treatment, and control of hypertension among HIV positive adults on antiretroviral treatment in public sector treatment programs in South Africa PLOS ONE

Cahn P, Sax PE, Squires K, Molina JM, Ratanasuwan W, Rassool M, Bloch M, Xu X, Zhou Y, Homony B, Hepler D, Teppler H, Hanna GJ, Nguyen BY, Greaves W; ONCEMRK Study Group. Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial. J Acquir Immune DeficSyndr. 2018 Aug 15;78(5):589-598. doi: 10.1097/QAI.0000000000001723. PubMed PMID: 29771789; PubMed Central PMCID: PMC6075877.

Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ. Cost-effectiveness of cervical cancer screening in women living with HIV in South Africa: A mathematical modeling study.J Acquir Immune DeficSyndr. 2018, Oct1, 79(2):195-205.
doi: 10.1097/QAI.0000000000001778. PMID: 29916959

Cespedes MS, Kang M, Kojic EM, Umbleja T, Godfrey C, Webster-Cyriaque JY, Masih R, Firnhaber C, Grinsztejn B, Saah A, Cu-Uvin S, Aberg JA. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.Papillomavirus Res. 2018 Aug 16;6:15-21. doi: 10.1016/j.pvr.2018.08.002. [Epub ahead of print]

Chibwesha CJ, Goeieman B, Levin S, Mulongo M, Faesen M, Swarts A, Ramotshela S, Williams S, Rakhombe N, Bruce S, Michelow P, Firnhaber C. Estimating the burden of cervical disease among HIV-infected women accessing screening services in South Africa: A model-based analysis.S Afr Med J. 2018 Feb 27;108(3):235-239. doi: 10.7196/SAMJ.2018.v108i3.12627. PMID:30004369

Clouse K, P Fox M.P, Mongwenyana C, Motlhatlhedi M, Buthelezi S, Bokaba D, Norris S.A, Bassett J, Lurie M.N, David M Aronoff D.M2 and Vermund S.H. “I will leave the baby with my mother”: Long-distance travel and follow-up care among HIV-positive pregnant and postpartum women in South Africa. Journal of the International AIDS Society (2018). 21(S4):e25121 INROADS

Davies G, Firnhaber C, Pantanowitz L, Michelow P, The relationship between menopausal women infected with the human immunodeficiency virus and cervical atrophy: A cytologic study. Diagnostic Cytopathology, April 2019, 47:4, 302-306.

de Waal R, Cohen K, Boulle A, Fox M.P, Maartens G, Igumbor E.U, Davies M.Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts. PLoS ONE 13(9): e0203530.

Dovel K, Shaba F, Nyirenda M, Offorjebe, Balakasi K, Phiri K, Nichols B, Tseng C, Bardon A, Ngona K and Hoffman R.Evaluating the integration of HIV self-testing into low-resource health systems: study protocol for a cluster-randomized control trial from EQUIP InnovationsTrials (2018) 19:498 NOT INROADS.

Evans D, Dahlberg S, Berhanu R, Sineke T, Govathson C, Jonker I, Lönnermark E, Fox M.P. Social and behavioral factors associated with failing second-line ART – results from a cohort study at the ThembaLethu Clinic, Johannesburg, South Africa AIDS CARE (2018) 30(7): 863-870 INROADS.

Evans D, Hirasen K, Berhanu R, Malete G, Ive P, Spencer D, BadalFaesen S, Sanne I.M and Fox M.P. Predictors of switch to and early outcomes on third‑line antiretroviral therapy at a large public‑sector clinic in Johannesburg, South Africa AIDS Res Ther (2018) 15:10

Ferrian S, Ross M, Conradie F, Vally Omar S, Ismail N, Little F, Kaplan G, Fallows D, and GrayCM. Frequency of Circulating CD4+Ki67+HLA-DR T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion. Front Immunol. 2018; 9: 2438. Published online 2018 Oct 25. doi: 10.3389/fimmu.2018.02438.

Fox M.P, Pascoe SJ, Huber AN, Murphy J, Phokojoe M, Gorgens M, Rosen M, Wilson D, Pillay Y, Fraser-Hurt N. Assessing the impact of the National Department of Health’s National Adherence Guidelines for Chronic Diseases in South Africa using routinely collected data: a cluster-randomised evaluationBMJ Open (2018) 8:e019680 NOT INROADS.

Fox M.P, Pascoe S.J.S, Huber A.N, Murphy J, Phokojoe M, Gorgens M, Rosen S, Wilson D, Pillay Y and Fraser-Hurt N. Effectiveness of interventions for unstable patients on antiretroviral therapy in South Africa: results of a cluster-randomised evaluation. Trop Med Int Health. 2018 Dec;23(12):1314-1325. doi: 10.1111/tmi.13152. Epub 2018 Oct 24.

Fox M.P, Bor J, Brennan A.T, MacLeod W.B, Maskew M, Stevens W.S, Carmona S. Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa. PLoS Med (2018). 15(6): e1002589. NOT INROADS

Fox MP, Kaufman JS. The WelTel Trial in context and the importance of null findings. Lancet Public Health (2018). (18)30004-5 NOT INROADS.

Haas A.D, Zaniewski E, Anderegg N, Ford N, Fox M.P, Vinikoor M, Dabis F, Nash D, Sinayobye J.D, Niyongabo T, Tanon A, Poda A, Adedimeji AA, Edmonds A, Davies M, Egger M. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes Journal of the International AIDS Society (2018). 21:e25084 INROADS

Hendrickson C.J, Pascoe S.J.S, Huber A.N, Moolla A, Maskew M, Long L.C and Fox M.P .“My future is bright. . .I won’t die with the cause of AIDS”: ten-year patient ART outcomes and experiences in South Africa Journal of the International AIDS Society 2018, 21:e25184 INROADS

Hirasen K, BerhanuR, Evans D, Rosen S, Sanne I, Long L.
High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.PLoS One. 2018 Oct 9;13(10):e0205463. doi: 10.1371/journal.pone.0205463. eCollection 2018. PMID: 30300403. PMCID: PMC6177165 DOI:

Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin JN, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok M, Samaneka W, Moses A, Mngqbisa R, Busakhala N, Martínez-Maza O, Ambinder R, Dittmer DP, Nokta M, Campbell TB; A5264/AMC-067 REACT-KS Team. As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis. 2018 Jul 2;67(2):251-260. doi: 10.1093/cid/ciy044. PMID:29365083

Ismail NA, McCarthy K, Conradie F, Steven W, Ndjeka N. Multidrug-resistant tuberculosis outbreak in South Africa. Lancet Infectious Diseases 2018 Dec 6 Online, doi:10.1016/S1473-3099(18)3-715-1.

Johnston D, Khan R, Miot J, Moch S, Van Deventer Y and Richards G. Usage of antibiotics in the intensive care units of an academic tertiary-level hospital. Southern African Journal of Infectious Diseases (2018). 0(0):1–8 NOT INROADS

Kluberg S.A, Fox M.P, LaValley M, Pillay D, Barnighausen T, and Jacob Bor. Do HIV treatment eligibility expansions crowd out the sickest? Evidence from rural South Africa. Tropical Medicine and International Health, doi:10.1111/tmi.13122 INROADS

Kredo T, Wiseman R, Gray A, Parrish A, Miot J. How good are our guidelines? Four years of experience with the SAMJ’s AGREE II review of submitted clinical practice guidelines SAMJ Nov 2018 Vol.108, No 11 NOT INROADS’s_AGREE_II_review_of_submitted_clinical_practice_guidelines

LaRee Tracy A, Struble K, Firnhaber C, Smeaton L, Lake JE, Bell T, Soon G, Yan J, Schnippel K, Cohn SE. Age Differences by Sex in Antiretroviral-Naïve Participants: Pooled Analysis from Randomized Clinical Trials.J Assoc Nurses AIDS Care. 2018 Feb 2. pii: S1055-3290(18)30024-4. doi: 0.1016/j.jana.2018.01.004. [Epub ahead of print] PMID: 29475784

Lince-Deroche N, van Rensburg C, Roseleur R, Sanusi B, Phiri J, Michelow P, Smith J.S, Firnhaber C. Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa. PLoS ONE 13(10): e0203921. INROADS

Long L.C, Evans D.H, Rosen S, Sauls C, Brennan A.T, Sanne I.M, Fox M.P. Can routine inpatient mortality data improve HIV mortality estimates? Inpatient mortality at an urban hospital in South Africa. SAMJ October 2018 Vol 108 No. 10 INROADS

Maskew M, Jamieson L, Mohomi G, Long L, Mongwenyana C, Nyoni C, Mokaba D, Fox M.P, Sanne I, Rosen S. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care. PLoS ONE 13(8): e0201955. NOT INROADS (NIH)

Meyer-Rath G, McGillen J.B, Cuadros D.F, Hallett TB, Bhatt S, Wabiri N, Tanser F, and Rehle T. Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning. AIDS (2018). 32:957–963 INROADS

Molina JM, Grund B, Gordin F, Williams I, Schechter M, Losso M, Law M, Ekong E, Mwelase N, Skoutelis A, Wiselka MJ, Vandekerckhove L, Benfield T, Munroe D, Lundgren JD, Neaton JD; Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. INSIGHT START study group. Lancet HIV. 2018 Apr;5(4):e172-e180. doi: 10.1016/S2352-3018(18)30003-1. Epub 2018 Jan 16. PMID: 29352723

Moorhouse MA, Carmona S, Davies N, Dlamini S, Cloete van Vuuren, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, van Zyl G, Conradie F, Venter F, Meintjes G. Appropriate clinical use of Darunavir 800mg.Afr J HIV Med. 2018, Oct 18:19(1):918. Doi: 10.4102/sajhivmed.v19I1.918.eCollection 2018.
Mulongo M, Oberlin AM, Firnhaber C, Goeieman B, Ramotshela S, Michelow P, Jordaan S, Chibwesha CJ. A two-step quality-improvement intervention to address Pap smear quality at public health facilities in South Africa.S Afr Med J. 2018 Oct 26;108(11):926-928. doi: 10.7196/SAMJ.2018.v108i11.13153.

Nattey C,Jinga N, Mongwenyana C, Mokhele I, Mohomi G, Fox M.P, and DorinaOnoya D. Understanding Predictors of Early Antenatal Care Initiation in Relationship to Timing of HIV Diagnosis in South Africa.AIDS PATIENT CARE and STDs (2018). 32(6) INROADS

Ndjeka N, Schnippel K, Master I, Meintjes G, Maartens G, Romero R, Padanilam X, Enwerem M, Chotoo S, Singh N, Hughes J, Variava E, Ferreira H, TeRiele J, Ismail N, Mohr E, Bantubani N, Conradie F. High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.Eur Respir J. 2018 Dec 20;52(6). pii: 1801528. doi: 10.1183/13993003.01528-2018.

Nichols B.E, Girdwood S.J, Crompton T, Stewart-Isherwood L, Berrie L, Chimhamhiwa D, Moyo C, Kuehnle J, Stevens W, Rosen S. Impact of a borderless sample transport network for scaling up viral load monitoring: results of a geospatial optimization model for Zambia. Journal of the International AIDS Society 2018, 21:e25206 NOT INROADS

Onoya D, Hirasen K, Van den Berg L, Miot J, Long L, Fox M.P. Adverse Drug Reactions Among Patients Initiating Second‑Line Antiretroviral Therapy in South Africa. Drug Safety (2018). INROADS

Palumbo PJ, Fogel JM, Hudelson SE, Wilson EA, Hart S, Hovind L, Piwowar-Manning E, Wallis C, Papathanasopoulos MA, Morgado MG, Saravanan S, Tripathy S, Eron JJ, Gallant JE, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Pilotto JH, Kumwenda J, Akelo V, Godbole SV, Santos BR, Grinsztejn B, Panchia R, Chariyalertsak S, Makhema J, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH. HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052.J Acquir Immune DeficSyndr. 2018 Apr 15;77(5):484-491. doi: 10.1097/QAI.0000000000001623. PubMed PMID: 29293156; PubMed Central PMCID: PMC5844834.

Papasavvas E, Kossenkov AV, Azzoni L, Zetola NM, Mackiewicz A, Ross BN, Fair M, Vadrevu S, Ramogola-Masire D, Sanne I, Firnhaber C, MontanerLJ.Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.Carcinogenesis. 2018 Oct 26. doi: 10.1093/carcin/bgy149. [Epub ahead of print]

Rohr J.K , Ive P, Horsburgh C.R, Berhanu R, Hoffmann C.J, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza M, Wandeler G, Davies M and Fox M.P .Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. J Acquir Immune DeficSyndr (2018). 77:413–416 INROADS

Rosen S, Maskew M, Brennan A.T, Fox M.P, Vezi L, Ehrenkranz P.D and Venter W.D.5. Improved simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE II): protocol for a randomized evaluation Trials (2018) 19:548 NOT INROADS

Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbellm TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firhnhaber C, Murphy R, Hall C, Marcus C, Naini L, Masih R, Hosseinipour MC, Mngqibisa R, Badal-Faesen S, Yosief S, Vecchio A, Nair A; AIDS Clinical Trials Group. HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings.Clin Infect Dis. 2018 Sep 13. doi: 10.1093/cid/ciy767. [Epub ahead of print] PubMed PMID: 30219843.

Robertson K, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell T, Hakim J, Tripathy S, Hosseinipour M, Marra CM; 5199 study team, Kumarasamy N, Evans S, Vecchio A, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Firnhaber C, Price R, Marcus C, Berzins B, Masih R, Lalloo U, Sanne I, Yosief S, Walawander A, Nair A, Sacktor N, Hall C; AIDS Clinical Trials Group. HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.

Clin Infect Dis. 2018 Aug 20. doi: 10.1093/cid/ciy718. [Epub ahead of print] PMID:30137250

Rohr J.K , Ive P, Horsburgh C.R, Berhanu R, Hoffmann C.J, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza M, Wandeler G, Davies M and Fox M.P .Assessing the Association Between Changing NRTIs When Initiating SecondLine ART and Treatment Outcomes. J Acquir Immune DeficSyndr (2018). 77:413–416 INROADS

Schnippel K, Firnhaber C, Berhanu R, Page-Shipp L, Sinanovic E. Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa.Int J Tuberc Lung Dis. 2018 Apr 1;22(4):393-398. doi: 10.5588/ijtld.17.0661. PMID:29562986

Schnippel K, Firnhaber C, Conradie F, Ndjeka N, Sinanovic E. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis. Appl Health Econ Health Policy. 2018 Feb;16(1):43-54. doi: 10.1007/s40258-017-0352-8. PubMed PMID: 28980217.

Schnippel K, Ndjeka N, Maartens G, Meintjes G, Master I, Ismail N, Hughes J , Ferreira H, Padanilam X, Romero R, TeRiele J, Conradie F.Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study. Lancet Respir Med. 2018 Sep;6(9):699-706. doi: 10.1016/S2213-2600(18)30235-2. Epub 2018 Jul 11. PMID:30001994

Shearer K, Evans D, Xhosa B, Hirasen K, Bracken C, Mahomed K, Long L, Fox M.P. Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg. South Africa PLoS ONE 13(9): e0203797 INROADS

Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A; NWCS 319 and ACTG PEARLS Study Team. Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial ClinNutr. 2018 May 29. pii: S0261-5614(18)30199-7. doi: 10.1016/j.clnu.2018.05.014. [Epubahead of print] PubMed PMID: 29885777.

Shivakoti R, Gupte N, Tripathy S, Poongulali S, Kanyama C, Berendes S, Cardoso SW, Santos BR, La Rosa A, Mwelase N, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Bollinger RC, Balagopal A, Semba RD, Christian P, Campbell TB, Gupta A; NWCS 319 and PEARLS Study Team. Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study. BMC Med. 2018 Sep 24;16(1):161. doi: 10.1186/s12916-018-1150-3. PMID:30244671.

Spencer K, Mokhele I, and Firnhaber C. Congenital genital abnormalities detected during routine circumcision at a South African institution: a retrospective record review Afr Health Sci. 2018 Jun; 18(2): 352–358.
doi: 10.4314/ahs.v18i2.20.

Svensson EM, Svensson RJ, Te Brake LHM, Boeree MJ, Heinrich N, Konsten S, Churchyard G, Dawson R, Diacon AH, Kibiki GS, Minja LT, Ntingiya NE, Sanne I, Gillespie SH, Hoelscher M, Phillips PPJ, Simonsson USH, Aarnoutse R. The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.Clin Infect Dis. 2018 Jun 18;67(1):34-41. doi: 10.1093/cid/ciy026

Tariq S, Hoffman S, Ramjee G, Mantell JE, . Phillip JL, Blanchard K, Lince-Deroche N and Exner TM.“I did not see a need to get tested before, everything was going well with my health”: a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa. AIDS Care Volume 30, 2018 – Issue 1Pages 32-39.

Torres TS, Harrison LJ, La Rosa AM, Cardoso SW, Zheng L, Ngongondo M, Some F, Lalloo UG, Mwelase T, Collier AC, Hughes MD; AIDS Clinical Trials Group (ACTG) A5273 Study Group. Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS. 2018 Mar 13;32(5):583-593. doi:10.1097/QAD.0000000000001738. PMID:29334547